Abstract:Objective To investigate the clinical effect of ultra-early small bone window intracranial hematoma removal in the treatment of hemorrhage in the basal ganglia of hypertension.Methods A total of 81 patients with hemorrhage in the basal ganglia of hypertension admitted to Wuhan Xinzhou District People's Hospital from January 2019 to January 2021 were selected as the research objects,they was divided into the observation group(41 cases)and the control group(40 cases)according to random number table method.The observation group used the ultra-early small bone window intracranial hematoma removal,and the control group performed traditional bone valve craniotomy hematoma clearance.The hematoma clearance rate,operation time,intraoperative bleeding volume,the treatment effect and the dynamic changes of neuron-specific enolase(NSE)and S100 protein(S100)before and after operation were compared between the two groups,and the complications of the two groups were recorded.Results The amount of bleeding of the observation group was lower than that of the control group,and the operation time of the observation group was shorter than that of the control group,there were statistically significant(P<0.05).The levels of S100 and NSE at the time points of the observation group were lower than those of the control group,and there were statistically significant(P<0.05).There was no statistically significant in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Ultra-early small bone window intracranial hematoma removal and large bone flap craniotomy removal are equivalent in the treatment of hypertensive cerebral hemorrhage,and the security is equivalent,but the former has more advantages in terms of operation time,blood loss,and trauma to the patient.
陈西亚. 超早期小骨窗颅内血肿清除术治疗高血压基底节区出血的临床效果[J]. 中国当代医药, 2022, 29(10): 85-88.
CHEN Xiya. Clinical effect of ultra-early small bone window intracranial hematoma removal in the treatment of hemorrhage in basal ganglia of hypertension. 中国当代医药, 2022, 29(10): 85-88.